GemVax&KAEL Co.Ltd
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution p… Read more
GemVax&KAEL Co.Ltd (082270) - Net Assets
Latest net assets as of September 2025: ₩50.30 Billion KRW
Based on the latest financial reports, GemVax&KAEL Co.Ltd (082270) has net assets worth ₩50.30 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩157.67 Billion) and total liabilities (₩107.37 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩50.30 Billion |
| % of Total Assets | 31.9% |
| Annual Growth Rate | -3.44% |
| 5-Year Change | -78.55% |
| 10-Year Change | -39.2% |
| Growth Volatility | 36.14 |
GemVax&KAEL Co.Ltd - Net Assets Trend (2010–2024)
This chart illustrates how GemVax&KAEL Co.Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for GemVax&KAEL Co.Ltd (2010–2024)
The table below shows the annual net assets of GemVax&KAEL Co.Ltd from 2010 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩29.01 Billion | -73.15% |
| 2023-12-31 | ₩108.02 Billion | -19.60% |
| 2022-12-31 | ₩134.35 Billion | -12.75% |
| 2021-12-31 | ₩153.99 Billion | +13.89% |
| 2020-12-31 | ₩135.21 Billion | +42.39% |
| 2019-12-31 | ₩94.95 Billion | -16.57% |
| 2018-12-31 | ₩113.81 Billion | +70.01% |
| 2017-12-31 | ₩66.94 Billion | +25.30% |
| 2016-12-31 | ₩53.43 Billion | +12.00% |
| 2015-12-31 | ₩47.70 Billion | +8.58% |
| 2014-12-31 | ₩43.94 Billion | -34.00% |
| 2013-12-31 | ₩66.57 Billion | +8.62% |
| 2012-12-31 | ₩61.29 Billion | -17.04% |
| 2011-12-31 | ₩73.88 Billion | +56.01% |
| 2010-12-31 | ₩47.35 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to GemVax&KAEL Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6834.2% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₩20.00 Billion | 68.94% |
| Other Components | ₩192.43 Billion | 663.40% |
| Total Equity | ₩29.01 Billion | 100.00% |
GemVax&KAEL Co.Ltd Competitors by Market Cap
The table below lists competitors of GemVax&KAEL Co.Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MannKind Corp
NASDAQ:MNKD
|
$822.37 Million |
|
Kiatnakin Bank Public Company. Ltd
OTCGREY:KNFSF
|
$822.43 Million |
|
Lovisa Holdings Ltd
AU:LOV
|
$822.49 Million |
|
Viglacera Corp JSC
VN:VGC
|
$823.17 Million |
|
Tianneng Battery Group Co Ltd
SHG:688819
|
$821.98 Million |
|
Bic Camera Inc
F:1U3
|
$821.82 Million |
|
Xiamen Meiya Pico Information
SHE:300188
|
$820.69 Million |
|
Apollo Medical Holdings Inc
F:3AM
|
$820.67 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GemVax&KAEL Co.Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 108,018,656,370 to 29,005,833,960, a change of -79,012,822,410 (-73.1%).
- Net loss of 87,218,733,400 reduced equity.
- Other factors increased equity by 8,205,910,990.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-87.22 Billion | -300.69% |
| Other Changes | ₩8.21 Billion | +28.29% |
| Total Change | ₩- | -73.15% |
Book Value vs Market Value Analysis
This analysis compares GemVax&KAEL Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 52.39x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 21.93x to 52.39x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1746.59 | ₩38300.00 | x |
| 2017-12-31 | ₩2189.03 | ₩38300.00 | x |
| 2018-12-31 | ₩3239.42 | ₩38300.00 | x |
| 2019-12-31 | ₩2475.53 | ₩38300.00 | x |
| 2020-12-31 | ₩3425.48 | ₩38300.00 | x |
| 2021-12-31 | ₩3880.11 | ₩38300.00 | x |
| 2022-12-31 | ₩3420.24 | ₩38300.00 | x |
| 2023-12-31 | ₩2740.38 | ₩38300.00 | x |
| 2024-12-31 | ₩731.00 | ₩38300.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently GemVax&KAEL Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -300.69%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -139.12%
- • Asset Turnover: 0.42x
- • Equity Multiplier: 5.20x
- Recent ROE (-300.69%) is below the historical average (-66.53%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 2.89% | 1.89% | 0.46x | 3.34x | ₩-3.09 Billion |
| 2014 | -300.81% | -31.66% | 0.95x | 9.99x | ₩-33.06 Billion |
| 2015 | -5.14% | -3.27% | 0.42x | 3.78x | ₩-7.22 Billion |
| 2016 | -39.21% | -73.75% | 0.15x | 3.55x | ₩-26.29 Billion |
| 2017 | -18.33% | -25.63% | 0.30x | 2.40x | ₩-18.97 Billion |
| 2018 | -9.41% | -22.66% | 0.27x | 1.52x | ₩-22.09 Billion |
| 2019 | -97.00% | -215.88% | 0.26x | 1.72x | ₩-101.60 Billion |
| 2020 | 1.21% | 2.49% | 0.41x | 1.17x | ₩-11.89 Billion |
| 2021 | 7.83% | 19.97% | 0.35x | 1.12x | ₩-3.34 Billion |
| 2022 | -14.59% | -25.86% | 0.50x | 1.12x | ₩-33.04 Billion |
| 2023 | -25.16% | -37.64% | 0.53x | 1.25x | ₩-37.98 Billion |
| 2024 | -300.69% | -139.12% | 0.42x | 5.20x | ₩-90.12 Billion |
Industry Comparison
This section compares GemVax&KAEL Co.Ltd's net assets metrics with peer companies in the Semiconductors & Semiconductor Equipment industry.
Industry Context
- Industry: Semiconductors & Semiconductor Equipment
- Average net assets among peers: $97,387,989,500
- Average return on equity (ROE) among peers: 5.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GemVax&KAEL Co.Ltd (082270) | ₩50.30 Billion | 2.89% | 2.13x | $822.25 Million |
| Fidelix Co. Ltd (032580) | $47.55 Billion | -4.64% | 0.19x | $8.98 Million |
| Cloud Air Co.Ltd (036170) | $123.98 Billion | 4.45% | 0.01x | $66.69 Million |
| UNISEM Co. Ltd (036200) | $199.44 Billion | 9.82% | 0.18x | $135.48 Million |
| JUSUNG ENGINEERING Co. Ltd (036930) | $114.13 Billion | 6.75% | 1.70x | $1.42 Billion |
| Lumens Co. Ltd (038060) | $97.80 Billion | 4.10% | 0.50x | $20.25 Million |
| meerecompany Incorporated (049950) | $112.91 Billion | 10.59% | 0.18x | $52.60 Million |
| I&C Technology Co. Ltd (052860) | $44.51 Billion | -0.67% | 0.51x | $23.89 Million |
| KMH Hitech Co. Ltd (052900) | $6.44 Billion | 0.00% | 9.67x | $17.04 Million |
| 3S KOREA Co. Ltd (060310) | $42.99 Billion | 0.00% | 0.66x | $38.66 Million |
| Tokai Carbon Korea Co. Ltd (064760) | $184.14 Billion | 25.45% | 0.16x | $761.70 Million |